Skip to main content

Clinical and Translational Oncology

Ausgabe 9/2024

Inhalt (29 Artikel)

Association between thyroid disorders and extra-thyroidal cancers, a review

  • REVIEW ARTICLE

Xin Jia, Jingru Li, Zongliang Jiang

Advances in tumor vascular growth inhibition

  • REVIEW ARTICLE

Keyong Zhang, Yuanyuan Shi, Ze Jin, Jian He

Current status of neoadjuvant immunotherapy for the treatment of gastric cancer

  • REVIEW ARTICLE

Xijie Zhang, Bo Liu, Rui Wang, Xin Li, Wence Zhou

In vivo safety evaluation method for nanomaterials for cancer therapy

  • REVIEW ARTICLE

Mengqi Chen, Jingyi Hei, Yan Huang, Xiyu Liu, Yong Huang

Evolution of radiation-induced dermatitis treatment

  • REVIEW ARTICLE

Deng Guangmei, He Weishan, Liu Wenya, Wu Fasheng, Chen Jibing

The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review

  • REVIEW ARTICLE

Wenxin Da, Ziyu Song, Xiaodong Liu, Yahui Wang, Shengjun Wang, Jie Ma

Logistic regression and other statistical tools in diagnostic biomarker studies

  • Open Access
  • CLINICAL GUIDES IN ONCOLOGY

Dina Mohamed Ahmed Samir Elkahwagy, Caroline Joseph Kiriacos, Manar Mansour

Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma

  • RESEARCH ARTICLE

Juanyi Shi, Kai Wen, Sintim Mui, Huoming Li, Hao Liao, Chuanchao He, Yongcong Yan, Zhenyu Zhou, Zhiyu Xiao

Enhanced outcomes in residual or recurrent craniopharyngioma: evaluating combined gamma knife and phosphorus-32 brachytherapy

  • RESEARCH ARTICLE

Jie Ma, Tao Chen, Jianning Zhang, Weidong Cao, Gan Gao, Xinguang Yu, Hongwei Wang

Molecular characterization of Chinese patients with small bowel adenocarcinoma

  • RESEARCH ARTICLE

Bryan Jin, Bin Lv, Zhengqing Yan, Wenshuai Li, Huan Song, Haoshu Cui, Yao Liu, Bin Zhong, Xin Shen, Xiao Li, Bei Zhang, Shiqing Chen, Wanwei Zheng, Jie Liu, Feifei Luo, Zhongguang Luo

Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study

  • Open Access
  • RESEARCH ARTICLE

Alejandro Falcón González, Josefina Cruz Jurado, Elisenda Llabrés Valenti, Rocío Urbano Cubero, Maria Carmen Álamo de la Gala, María Antonia Martínez Guisado, Rocío Álvarez Ambite, Carlos José Rodríguez González, Marta Amérigo Góngora, Lourdes Rodríguez Pérez, Pilar López Álvarez, Pedro Sánchez Rovira, Encarnación González Flores, Fernando Henao Carrasco, Juan Bayo Calero, María Valero Arbizu, Alicia Quílez Cutillas, Javier Salvador Boffil, Eloísa Rubio Pérez, Manuel Ruiz-Borrego

Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration

  • Open Access
  • RESEARCH ARTICLE

Vered Fuchs, Ariel Sobarzo, Maha Msamra, Yarden Kezerle, Liat Linde, Gur Sevillya, Alaa Anoze, Yael Refaely, Ahron Yehonatan Cohen, Israel Melamed, Amit Azriel, Rami Shoukrun, Yael Raviv, Angel Porgador, Nir Peled, Laila Catalina Roisman

The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma

  • Open Access
  • RESEARCH ARTICLE

Wenjing Xiong, Liru Li, Xue Hui, Yue Liu, Hongbin Li, Yue Zhang, Shu Zhao

Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway

  • RESEARCH ARTICLE

Zi-Yi Fu, Ying Huang, Le-Shen Lian, Hui-Ting Huang, Shao-Feng Zhan, Yan Cai, Jun-Xiong Li, Xiao-Hong Liu

Development and validation of a novel scoring system based on a nomogram for predicting inadequate bowel preparation

  • RESEARCH ARTICLE

Xiaxia Zhao, Yanglin Pan, Jinyong Hao, Jie Feng, Zhongyuan Cui, Huimin Ma, Xiaojun Huang

Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures

  • RESEARCH ARTICLE

Lidan Chang, Dandan Liu, Xuyan Zhao, Luyao Dai, Xueting Ren, Qian Hao, Peinan Liu, Hao Wu, Xiaobin Ma, Huafeng Kang

Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer

  • RESEARCH ARTICLE

Song Mi, Yunxin Yang, Xin Liu, Shaotong Tang, Ning Liang, Jinyue Sun, Chao Liu, Qidong Ren, Jihong Lu, Pingping Hu, Jiandong Zhang

ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

  • Open Access
  • RESEARCH ARTICLE

Antonio Juan-Ribelles, Francisco Bautista, Adela Cañete, Alba Rubio-San-Simón, Anna Alonso-Saladrigues, Raquel Hladun, Susana Rives, Jose Luís Dapena, Jose María Fernández, Álvaro Lassaletta, Ofelia Cruz, Gemma Ramírez-Villar, Jose Luís Fuster, Cristina Diaz de Heredia, Miguel García-Ariza, Eduardo Quiroga, María del Mar Andrés, Jaime Verdú-Amorós, Antonio Molinés, Blanca Herrero, Mónica López, Catalina Márquez, María Toboso, Frencisco Lendínez, Jose Gómez Sirvent, María Tallón, Guiomar Rodríguez, Tomás Acha, Lucas Moreno, Ana Fernández-Teijeiro

Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer

  • RESEARCH ARTICLE

Wenhao Lu, Lin Zhao, Shenfan Wang, Huiyong Zhang, Kangxian Jiang, Jin Ji, Shaohua Chen, Chengbang Wang, Chunmeng Wei, Rongbin Zhou, Zuheng Wang, Xiao Li, Fubo Wang, Xuedong Wei, Wenlei Hou

Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: a cross-sectional study

  • RESEARCH ARTICLE

Chen-yu Ma, Xin-yu Liang, Liang Ran, Lei Hu, Fan-ling Zeng, Rui-ling She, Jun-han Feng, Zhi-yu Jiang, Zhao-xing Li, Xiu-quan Qu, Bai-qing Peng, Kai-nan Wu, Ling-quan Kong

Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

  • BRIEF RESEARCH ARTICLE

Irene González Caraballo, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Javier Soto Alsar, Laura Ortega Morán, Miguel Martín Jiménez, Andrés J. Muñoz Martín

Correction: Logistic regression and other statistical tools in diagnostic biomarker studies

  • Open Access
  • Correction

Dina Mohamed Ahmed Samir Elkahwagy, Caroline Joseph Kiriacos, Manar Mansour

Neu im Fachgebiet Onkologie

Kopf-Hals-Tumoren: Die Immuntherapie ist kein Selbstläufer

Ergebnisse einer weiteren Studie legen nahe: Mit einer adjuvanten Immuncheckpointhemmung ist lokal fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereichs nur schwer beizukommen. Einige Fachleute geben die Hoffnung jedoch nicht auf und diskutieren mögliche Gründe für die negativen Ergebnisse.

Dänische Zwillingsstudie deutet auf erhöhtes Krebsrisiko bei Tätowierten hin

Haben Tattoo-Träger und -Trägerinnen ein erhöhtes Risiko, an Hautkrebs oder einem Lymphom zu erkranken? Die Ergebnisse einer Zwillingsstudie aus Dänemark scheinen dafür zu sprechen. Die Forschungsgruppe rät vorerst zur Zurückhaltung beim Tätowieren.

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.